Free Trial
NASDAQ:SRTS

Sensus Healthcare (SRTS) Stock Price, News & Analysis

Sensus Healthcare logo
$4.69 +0.24 (+5.39%)
Closing price 04:00 PM Eastern
Extended Trading
$4.75 +0.06 (+1.28%)
As of 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Sensus Healthcare Stock (NASDAQ:SRTS)

Key Stats

Today's Range
$4.44
$4.75
50-Day Range
$4.45
$8.99
52-Week Range
$2.91
$9.33
Volume
241,379 shs
Average Volume
392,845 shs
Market Capitalization
$76.86 million
P/E Ratio
11.73
Dividend Yield
N/A
Price Target
$14.67
Consensus Rating
Buy

Company Overview

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Sensus Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
67th Percentile Overall Score

SRTS MarketRank™: 

Sensus Healthcare scored higher than 67% of companies evaluated by MarketBeat, and ranked 344th out of 947 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sensus Healthcare has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Sensus Healthcare has only been the subject of 2 research reports in the past 90 days.

  • Read more about Sensus Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Sensus Healthcare are expected to decrease by -28.13% in the coming year, from $0.32 to $0.23 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sensus Healthcare is 11.73, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.54.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sensus Healthcare is 11.73, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 25.17.

  • Price to Book Value per Share Ratio

    Sensus Healthcare has a P/B Ratio of 1.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Sensus Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    8.77% of the float of Sensus Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Sensus Healthcare has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Sensus Healthcare has recently decreased by 23.87%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Sensus Healthcare does not currently pay a dividend.

  • Dividend Growth

    Sensus Healthcare does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.77% of the float of Sensus Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Sensus Healthcare has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Sensus Healthcare has recently decreased by 23.87%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Sensus Healthcare has a news sentiment score of 1.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Sensus Healthcare this week, compared to 2 articles on an average week.
  • Search Interest

    20 people have searched for SRTS on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    13 people have added Sensus Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 550% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Sensus Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.40% of the stock of Sensus Healthcare is held by insiders.

  • Percentage Held by Institutions

    Only 25.30% of the stock of Sensus Healthcare is held by institutions.

  • Read more about Sensus Healthcare's insider trading history.
Receive SRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SRTS Stock News Headlines

Sensus Healthcare participates in a conference call with Lake Street
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…
Sensus resumed purchasing of stock under $3M share repurchase program
Sensus Healthcare price target raised to $12 from $11 at H.C. Wainwright
Sensus Healthcare (SRTS) Gets a Buy from Maxim Group
Sensus Healthcare: A Tough Q1 2025 Awaits Ahead
See More Headlines

SRTS Stock Analysis - Frequently Asked Questions

Sensus Healthcare's stock was trading at $6.92 at the beginning of the year. Since then, SRTS stock has decreased by 32.2% and is now trading at $4.69.
View the best growth stocks for 2025 here
.

Sensus Healthcare, Inc. (NASDAQ:SRTS) posted its earnings results on Wednesday, February, 5th. The company reported $0.09 EPS for the quarter, missing analysts' consensus estimates of $0.10 by $0.01. Sensus Healthcare had a trailing twelve-month return on equity of 12.60% and a net margin of 15.90%.

Sensus Healthcare (SRTS) raised $20 million in an initial public offering (IPO) on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company served as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

Sensus Healthcare's top institutional shareholders include Renaissance Technologies LLC (2.63%), Dimensional Fund Advisors LP (2.31%), Arrowstreet Capital Limited Partnership (0.92%) and Marshall Wace LLP (0.81%). Insiders that own company stock include Joseph C Sardano, William H Mccall, Samuel O'rear, John Heinrich, Michael Sardano and Nicolas Soro.
View institutional ownership trends
.

Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sensus Healthcare investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), CrowdStrike (CRWD), EMCOR Group (EME), e.l.f. Beauty (ELF) and Arista Networks (ANET).

Company Calendar

Last Earnings
2/05/2025
Today
3/05/2025
Next Earnings (Estimated)
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SRTS
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.67
High Stock Price Target
$18.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+220.6%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
11.46
Forward P/E Ratio
14.30
P/E Growth
N/A
Net Income
$6.65 million
Pretax Margin
31.16%

Debt

Sales & Book Value

Annual Sales
$41.81 million
Cash Flow
$0.05 per share
Price / Cash Flow
96.29
Book Value
$2.98 per share
Price / Book
1.54

Miscellaneous

Free Float
14,848,000
Market Cap
$74.98 million
Optionable
Optionable
Beta
1.28

Social Links

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NASDAQ:SRTS) was last updated on 3/5/2025 by MarketBeat.com Staff
From Our Partners